Emerging Concepts in Congenital Cytomegalovirus

Area of Science:

• Virology
• Immunobiology
• Infectious Diseases

Background:

• Congenital cytomegalovirus (cCMV) is the leading cause of congenital infection in the US, impacting 3-6 per 1000 live births annually.
• cCMV poses significant risks, including spontaneous abortion, intrauterine fetal demise, and long-term neurodevelopmental sequelae like sensorineural hearing loss in neonates.

Purpose of the Study:

• To review recent advancements in understanding cytomegalovirus (CMV) virology and immunobiology.
• To discuss how this knowledge informs cCMV pathophysiology and strategies for improving outcomes in congenitally infected children.
• To provide an update on cCMV epidemiology, maternal-fetal transmission, screening, and sequelae, and to recommend future research directions.

Main Methods:

• Review of recent scientific literature on cCMV.
• Synthesis of current knowledge on CMV virology, immunobiology, and pathophysiology.
• Analysis of epidemiological data, diagnostic strategies, therapeutics, and vaccine trials for cCMV.

Main Results:

• Significant progress has been made in cCMV epidemiology, transmission, diagnostics, screening, therapeutics, and vaccine development.
• Enhanced understanding of CMV virology and immunobiology is crucial for deciphering cCMV pathophysiology.
• Current research landscape includes evolving screening approaches and recognition of neonatal/long-term sequelae.

Conclusions:

• Continued research into cCMV is vital for improving the quality of life for infected children.
• Novel and high-priority research areas are identified to guide future investigations in pediatric cCMV.
• Advancements in understanding and management are critical for addressing the public health challenge of cCMV.